JCM
DXCM icon

Junto Capital Management’s DexCom DXCM Stock Holding History

Junto Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-503,428
Closed -$69.8M – 83
2024
Q1 		$69.8M Buy
+503,428
New +$63.3M 1.55% 25

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Junto Capital Management's DXCM Position: Q2 2024 in Review

Junto Capital Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 503,428 shares — an estimated $69.8M sold.

Junto Capital Management first reported a position in DXCM in Q1 2024 and held it in 1 quarter. The position peaked at $69.8M in Q1 2024. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Junto Capital Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Junto Capital Management sold 503,428 DexCom shares in Q2 2024, an estimated $69.8M.
  • Junto Capital Management first reported a position in DexCom in Q1 2024 and held it in 1 quarter.
  • Junto Capital Management's DexCom position peaked at $69.8M in Q1 2024.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Junto Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.